Covered recipient · General Payments record
RANDALL CAVINESS
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2018–2024
$4,439.93
- Reported across 239 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $512.71 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $298.76 | 16 |
| Lilly USA, LLC | $94.90 | 4 |
| Amgen Inc. | $28.21 | 1 |
| GlaxoSmithKline, LLC. | $21.98 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.44 | 1 |
| DEXCOM, INC. | $18.20 | 1 |
| Acerta Pharma LLC | $16.47 | 1 |
| Novo Nordisk AS | $15.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.67 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430552 | CMS |
| ABBVIE INC. | $21.94 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430554 | CMS |
| ABBVIE INC. | $7.22 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430556 | CMS |
| ABBVIE INC. | $8.39 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430558 | CMS |
| ABBVIE INC. | $23.06 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430560 | CMS |
| ABBVIE INC. | $24.23 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430562 | CMS |
| ABBVIE INC. | $23.93 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430564 | CMS |
| ABBVIE INC. | $12.55 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430566 | CMS |
| ABBVIE INC. | $32.40 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430568 | CMS |
| ABBVIE INC. | $14.50 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430570 | CMS |
| ABBVIE INC. | $14.02 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430572 | CMS |
| ABBVIE INC. | $16.58 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430574 | CMS |
| ABBVIE INC. | $25.71 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430576 | CMS |
| ABBVIE INC. | $9.73 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430578 | CMS |
| ABBVIE INC. | $24.42 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430580 | CMS |
| ABBVIE INC. | $26.41 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103430582 | CMS |
| Amgen Inc. | $28.21 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115485993 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.47 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105868689 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.44 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117925838 | CMS |
| Dexcom, Inc. | $18.20 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153329587 | CMS |
| GlaxoSmithKline, LLC. | $21.98 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116291174 | CMS |
| Lilly USA, LLC | $25.77 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135331568 | CMS |
| Lilly USA, LLC | $18.91 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135352149 | CMS |
| Lilly USA, LLC | $23.77 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135378472 | CMS |
| Lilly USA, LLC | $26.45 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135328823 | CMS |
| Novo Nordisk Inc | $15.75 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097052166 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.